Market research reports, consulting: Global Market Insights Inc.
We use cookies to enhance user experience. (Privacy Policy)

Central Lab Market Size

Report ID: GMI10831
   |
Published Date: August 2024
 | 
Report Format: PDF

Download free sample

Central Lab Market Size

Central Lab Market size was valued at around USD 3.1 billion in 2023 and is expected to reach around USD 5.1 billion by 2032 at a CAGR of 5.8% during the forecast period. The growing emphasis on outsourcing of testing services coupled with extensive growth in research and development investments are driving the market growth.

 

Central Lab Market

Outsourcing testing services is increasingly driving the growth of the central lab market, as organizations seek cost efficiency, high-quality outcomes, and specialized testing capabilities. The U.S. Food and Drug Administration (FDA) reported a 25% increase in clinical trials utilizing outsourced central laboratory services in 2022 compared to 2019, highlighting the growing reliance on these specialized labs for critical testing. This trend allows organizations to focus on their core activities while central labs provide precise and efficient testing, thereby accelerating market expansion.
 

A central lab is a dedicated facility or group of laboratories that provides comprehensive laboratory testing services for clinical trials, pharmaceutical research, and various diagnostic purposes. These labs are equipped with advanced technologies and staffed by skilled professionals to conduct a wide range of tests and analyses on biological samples, including blood, urine, tissue, and other specimens.
 

Authors: Mariam Faizullabhoy, Gauri Wani
Frequently Asked Question(FAQ) :
Who are the major central lab industry players?
A.P. Moller Holding A/S, ACM Global Laboratories, BioAgilytix Labs, Cerba Research, Cirion Biopharma Research Inc., Covance Inc., Eurofins Scientific, Frontage Laboratories, ICON Central Laboratories, and LabConnect, among others.
Why is the central lab industry booming in North America?
Why is the use of central labs rising in biomarker services?
How big is the central lab market?

Report Content

Chapter 1   Methodology & Scope

1.1    Market scope & definition

1.2    Research design

1.2.1    Research approach

1.2.2    Data collection methods

1.3    Base estimates & calculations

1.3.1    Base year calculation

1.3.2    Key trends for market estimation

1.4    Forecast model

1.5    Primary research and validation

1.5.1    Primary sources

1.5.2    Data mining sources

Chapter 2   Executive Summary

2.1    Industry 3600 synopsis

Chapter 3   Industry Insights

3.1    Industry ecosystem analysis

3.2    Industry impact forces

3.2.1    Growth drivers

3.2.1.1    Growing emphasis on outsourcing of testing services

3.2.1.2    Technological advancements in testing equipment

3.2.1.3    Extensive growth in research and development investments

3.2.2    Industry pitfalls & challenges

3.2.2.1    Stringent government regulations and compliance

3.3    Growth potential analysis

3.4    Regulatory landscape

3.5    Technological landscape

3.6    Porter's analysis

3.7    PESTEL analysis

3.8    Future market trends

Chapter 4   Competitive Landscape, 2023

4.1    Introduction

4.2    Company matrix analysis

4.3    Competitive analysis of major market players

4.4    Competitive positioning matrix

4.5    Strategy dashboard

Chapter 5   Market Estimates and Forecast, By Services, 2021 – 2032 ($ Mn)

5.1    Key trends

5.2    Genetic services

5.3    Biomarker services

5.4    Microbiology services

5.5    Anatomic pathology/histology

5.6    Specimen management & storage

5.7    Other services

Chapter 6   Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)

6.1    Key trends

6.2    Oncology

6.3    Neurology

6.4    Cardiology

6.5    Infectious diseases

6.6    Other applications

Chapter 7   Market Estimates and Forecast, By End-use, 2021 – 2032 ($ Mn)

7.1    Key trends

7.2    Pharmaceutical and biotechnology companies

7.3    Academic and research institutes

7.4    Other end-users

Chapter 8   Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)

8.1    Key trends

8.2    North America

8.2.1    U.S.

8.2.2    Canada

8.3    Europe

8.3.1    Germany

8.3.2    UK

8.3.3    France

8.3.4    Italy

8.3.5    Spain

8.3.6    Netherlands

8.3.7    Rest of Europe

8.4    Asia Pacific

8.4.1    China

8.4.2    Japan

8.4.3    India

8.4.4    Australia

8.4.5    South Korea

8.4.6    Rest of Asia Pacific

8.5    Latin America

8.5.1    Brazil

8.5.2    Mexico

8.5.3    Argentina

8.5.4    Rest of Latin America

8.6    Middle East and Africa

8.6.1    Saudi Arabia

8.6.2    South Africa

8.6.3    UAE

8.6.4    Rest of Middle East and Africa

Chapter 9   Company Profiles

9.1    A.P. Moller Holding A/S

9.2    ACM Global Laboratories

9.3    BioAgilytix Labs

9.4    Cerba Research

9.5    Cirion Biopharma Research Inc.

9.6    Covance Inc.

9.7    Eurofins Scientific

9.8    Frontage Laboratories

9.9    ICON Central Laboratories

9.10    LabConnect

9.11    Laboratory Corporation of America Holding

9.12    Lambda Therapeutics Research Ltd

9.13    Medpace, Inc.

9.14    Parexel International Corporation

9.15    Quest Diagnostics

9.16    Versiti

Authors: Mariam Faizullabhoy, Gauri Wani
Buy Now
$4,123 $4,850
15% off
$4,840 $6,050
20% off
$5,845 $8,350
30% off
    Buy now
Premium Report Details

Base Year: 2023

Companies covered: 16

Tables & Figures: 121

Countries covered: 23

Pages: 110

Download Free Sample

Top